The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The genomic landscape of juvenile myelomonocytic leukemia
Open accessAbstract
Juvenile myelomonocytic leukemia (JMML) is a myeloproliferative neoplasm (MPN) of childhood with a poor prognosis. Mutations in NF1, NRAS, KRAS, PTPN11 or CBL occur in 85% of patients, yet there are currently no risk stratification algorithms capable of predicting which patients will be refractory to conventional treatment and could therefore be candidates for experimental therapies. In addition, few molecular pathways aside from the RAS-MAPK pathway have been identified that could serve as the basis for such novel therapeutic strategies. We therefore sought to genomically characterize serial samples from patients at diagnosis through relapse and transformation to acute myeloid leukemia to expand knowledge of the mutational spectrum in JMML. We identified recurrent mutations in genes involved in signal transduction, splicing, Polycomb repressive complex 2 (PRC2) and transcription. Notably, the number of somatic alterations present at diagnosis appears to be the major determinant of outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Self-citationA Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Differential analysis of gene regulation at transcript resolution with RNA-seq
Trapnell, C., Hendrickson, D. G., Sauvageau, M., Goff, L., Rinn, J. L., & Pachter, L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2450 · Cited by 3,492
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Forbes, S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1075 · Cited by 2,283
Predicting the functional impact of protein mutations: application to cancer genomics
Reva, B., Antipin, Y., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr407 · Cited by 2,002
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Self-citationTartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
A faster circular binary segmentation algorithm for the analysis of array CGH data
Venkatraman, E. S., & Olshen, A. B. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl646 · Cited by 961
Self-citationLow-level processing of Illumina Infinium DNA Methylation BeadArrays
Triche, T. J., Weisenberger, D. J., Van Den Berg, D., Laird, P. W., & Siegmund, K. D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt090 · Cited by 905
Dulak, A. M., Stojanov, P., Peng, S., Lawrence, M. S., Fox, C., Stewart, C., Bandla, S., Imamura, Y., Schumacher, S. E., Shefler, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2591 · Cited by 735
Self-citationHsu, A. P., Sampaio, E. P., Khan, J., Calvo, K. R., Lemieux, J. E., Patel, S. Y., Frucht, D. M., Vinh, D. C., Auth, R. D., Freeman, A. F., et al. (2011) · Blood · doi:10.1182/blood-2011-05-356352 · Cited by 638
Hahn, C. N., Chong, C.-E., Carmichael, C. L., Wilkins, E. J., Brautigan, P. J., Li, X.-C., Babic, M., Lin, M., Carmagnac, A., Lee, Y. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.913 · Cited by 606
Ostergaard, P., Simpson, M. A., Connell, F. C., Steward, C. G., Brice, G., Woollard, W. J., Dafou, D., Kilo, T., Smithson, S., Lunt, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.923 · Cited by 506
Russler-Germain, D. A., Spencer, D. H., Young, M. A., Lamprecht, T. L., Miller, C. A., Fulton, R., Meyer, M. R., Erdmann-Gilmore, P., Townsend, R. R., Wilson, R. K., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.010 · Cited by 452
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Self-citationNiemeyer, C. M., Kang, M. W., Shin, D. H., Furlan, I., Erlacher, M., Bunin, N. J., Bunda, S., Finklestein, J. Z., Sakamoto, K. M., Gorr, T. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.641 · Cited by 374
Self-citationJankowska, A. M., Makishima, H., Tiu, R. V., Szpurka, H., Huang, Y., Traina, F., Visconte, V., Sugimoto, Y., Prince, C., O'Keefe, C., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311019 · Cited by 330
Oh, S. T., Simonds, E. F., Jones, C., Hale, M. B., Goltsev, Y., Gibbs, K. D., Merker, J. D., Zehnder, J. L., Nolan, G. P., & Gotlib, J. (2010) · Blood · doi:10.1182/blood-2010-02-270108 · Cited by 330
Side, L., Taylor, B., Cayouette, M., Conner, E., Thompson, P., Luce, M., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 295
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Loh, M. L., Sakai, D. S., Flotho, C., Kang, M., Fliegauf, M., Archambeault, S., Mullighan, C. G., Chen, L., Bergstraesser, E., Bueso-Ramos, C. E., et al. (2009) · Blood · doi:10.1182/blood-2009-01-198416 · Cited by 286
Self-citationKazenwadel, J., Secker, G. A., Liu, Y. J., Rosenfeld, J. A., Wildin, R. S., Cuellar-Rodriguez, J., Hsu, A. P., Dyack, S., Fernandez, C. V., Chong, C.-E., et al. (2012) · Blood · doi:10.1182/blood-2011-08-374363 · Cited by 279
Self-citationPoint mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Osato, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207779 · Cited by 268
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
Ribeiro, A. F. T., Pratcorona, M., Erpelinck-Verschueren, C., Rockova, V., Sanders, M., Abbas, S., Figueroa, M. E., Zeilemaker, A., Melnick, A., Löwenberg, B., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367961 · Cited by 262
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato-Otsubo, A., Kohlmann, A., Sanada, M., Grossmann, V., Sundaresan, J., Shiraishi, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7042 · Cited by 240
How I treat juvenile myelomonocytic leukemia
Locatelli, F., & Niemeyer, C. M. (2015) · Blood · doi:10.1182/blood-2014-08-550483 · Cited by 234
Kotecha, N., Flores, N. J., Irish, J. M., Simonds, E. F., Sakai, D. S., Archambeault, S., Diaz-Flores, E., Coram, M., Shannon, K. M., Nolan, G. P., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.014 · Cited by 233
Self-citationSegmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene
Tinschert, S., Naumann, I., Stegmann, E., Buske, A., Kaufmann, D., Thiel, G., & Jenne, D. E. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200493 · Cited by 230
Sakaguchi, H., Okuno, Y., Muramatsu, H., Yoshida, K., Shiraishi, Y., Takahashi, M., Kon, A., Sanada, M., Chiba, K., Tanaka, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2698 · Cited by 220
Pasquet, M., Bellanné-Chantelot, C., Tavitian, S., Prade, N., Beaupain, B., LaRochelle, O., Petit, A., Rohrlich, P., Ferrand, C., Van Den Neste, E., et al. (2013) · Blood · doi:10.1182/blood-2012-08-447367 · Cited by 217
Side, L. E., Emanuel, P. D., Taylor, B., Franklin, J., Thompson, P., Castleberry, R. P., & Shannon, K. M. (1998) · Blood · doi:10.1182/blood.v92.1.267.413a31_267_272 · Cited by 207
Self-citationRAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
Matsuda, K., Shimada, A., Yoshida, N., Ogawa, A., Watanabe, A., Yajima, S., Iizuka, S., Koike, K., Yanai, F., Kawasaki, K., et al. (2007) · Blood · doi:10.1182/blood-2006-09-046649 · Cited by 162
Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium
Chan, R. J., Cooper, T. M., Kratz, C. P., Weiss, B., & Loh, M. L. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.08.022 · Cited by 160
Self-citationFlex, E., Jaiswal, M., Pantaleoni, F., Martinelli, S., Strullu, M., Fansa, E. K., Caye‐Eude, A., Luca, A. D., Lepri, F. R., Dvorský, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu148 · Cited by 153
Self-citationLNKMutations inJAK2Mutation–Negative Erythrocytosis
Lasho, T. L., Pardanani, A. D., & Tefferi, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1006966 · Cited by 151
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
Chang, T. Y., Krisman, K., Theobald, E. H., Xu, J., Akutagawa, J., Lauchle, J., Kogan, S. C., Braun, B. S., & Shannon, K. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63193 · Cited by 130
Self-citationGenetic loss of SH2B3 in acute lymphoblastic leukemia
Pérez-García, A., Ambesi‐Impiombato, A., Hadler, M., Rigo, I., LeDuc, C. A., Kelly, K. M., Jalas, C., Paietta, E. M., Racevskis, J., Rowe, J. M., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500850 · Cited by 130
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
Gambacorti-Passerini, C. B., Donadoni, C., Parmiani, A., Pirola, A., Redaelli, S., Signore, G., Piazza, V., Malcovati, L., Fontana, D., Spinelli, R., et al. (2014) · Blood · doi:10.1182/blood-2014-06-579466 · Cited by 129
Chang, T. Y., Dvorak, C. C., & Loh, M. L. (2014) · Blood · doi:10.1182/blood-2014-03-300319 · Cited by 115
Self-citationFasan, A., Eder, C., Haferlach, C., Großmann, V., Kohlmann, A., Dicker, F., Kern, W., Haferlach, T., & Schnittger, S. (2012) · Leukemia · doi:10.1038/leu.2012.174 · Cited by 102
A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.
Chan, A. M.-L., Miki, T., Meyers, K. A., & Aaronson, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7558 · Cited by 94
A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
Lyubynska, N., Gorman, M. F., Lauchle, J., Hong, W. X., Akutagawa, J., Shannon, K., & Braun, B. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001069 · Cited by 92
Kar, S. A., Jankowska, A., Makishima, H., Visconte, V., Jerez, A., Sugimoto, Y., Muramatsu, H., Traina, F., Afable, M. G., Guinta, K. M., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.064048 · Cited by 88
Stephens, K. G., Weaver, M., Leppig, K. A., Maruyama, K., Emanuel, P. D., Beau, M. M. L., & Shannon, K. (2006) · Blood · doi:10.1182/blood-2005-11-011486 · Cited by 87
Self-citationSubclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia
Stieglitz, E., Troup, C. B., Gelston, L. C., Haliburton, J. R., Chow, E. D., Yu, K. B., Akutagawa, J., Taylor-Weiner, A. N., Liu, Y. L., Wang, Y., et al. (2014) · Blood · doi:10.1182/blood-2014-09-601690 · Cited by 79
Self-citationSpectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations
Sugimoto, Y., Muramatsu, H., Makishima, H., Prince, C. J., Jankowska, A. M., Yoshida, N., Xu, Y., Nishio, N., Hama, A., Yagasaki, H., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08196.x · Cited by 77
Bresolin, S., Zecca, M., Flotho, C., Trentin, L., Zangrando, A., Sainati, L., Starý, J., Moerloose, B. D., Hasle, H., Niemeyer, C. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4426 · Cited by 77
Perez, B., Kosmider, O., Cassinat, B., Renneville, A., Lachenaud, J., Kaltenbach, S., Bertrand, Y., Baruchel, A., Chomienne, C., Fontenay, M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08393.x · Cited by 74
TC21 and Ras share indistinguishable transforming and differentiating activities
Graham, S. M., Oldham, S., Martin, C. B., Drugan, J. K., Zohn, I. E., Campbell, S. L., & Der, C. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202517 · Cited by 72
Hirabayashi, S., Flotho, C., Moetter, J., Heuser, M., Hasle, H., Gruhn, B., Klingebiel, T. E., Thol, F. R., Schlegelberger, B., Baumann, I., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395087 · Cited by 71
Dvorak, C. C., & Loh, M. L. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00025 · Cited by 58
Self-citationLnk Adaptor: Novel Negative Regulator of B Cell Lymphopoiesis
Rudd, C. E. (2001) · Science s STKE · doi:10.1126/stke.2001.85.pe1 · Cited by 49
Archambeault, S., Flores, N. J., Yoshimi, A., Kratz, C. P., Reising, M., Fischer, A., Noellke, P., Locatelli, F., Sedláček, P., Flotho, C., et al. (2007) · Blood · doi:10.1182/blood-2007-06-093302 · Cited by 33
Self-citationA nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis
McMullin, M. F., Wu, C., Percy, M. J., & Tong, W. (2011) · American Journal of Hematology · doi:10.1002/ajh.22154 · Cited by 33
Yang, Z., Kondo, T., Voorhorst, C. S., Nabinger, S. C., Ndong, L., Yin, F., Chan, E. M., Yu, M., Würstlin, O., Kratz, C. P., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01330-08 · Cited by 32
In Vivo Regulation of TGF-β by R-Ras2 Revealed through Loss of the RasGAP Protein NF1
Patmore, D. M., Welch, S., Fulkerson, P. C., Wu, J., Choi, K., Eaves, D. W., Kordich, J. J., Collins, M. H., Cripe, T. P., & Ratner, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1972 · Cited by 26
Hurtado, C., Erquiaga, I., Aranaz, P., Miguéliz, I., García‐Delgado, M., Novo, F. J., & Vizmanos, J. L. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.07.009 · Cited by 24
Novel splicing-factor mutations in juvenile myelomonocytic leukemia
Takita, J., Yoshida, K., Sanada, M., Nishimura, R., Okubo, J., Motomura, A., Hiwatari, M., Oki, K., Igarashi, T., Hayashi, Y., et al. (2012) · Leukemia · doi:10.1038/leu.2012.45 · Cited by 12
Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Blood · doi:10.1182/blood.v122.21.437.437 · Cited by 1
Cited by
Khoury, J. D., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J. F., Bejar, R., Berti, E., Busque, L., Chan, J. K. C., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01613-1 · Cited by 4,274
Clonal evolution of glioblastoma under therapy
Wang, J., Cazzato, E., Ladewig, E., Frattini, V., Rosenbloom, D. I. S., Zairis, S., Abate, F., Liu, Z., Elliott, O., Shin, Y.-J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3590 · Cited by 720
Kortüm, K. M., Mai, E. K., Hanafiah, N. H., Shi, C.-X., Zhu, Y.-X., Bruins, L., Barrio, S., Jedlowski, P., Merz, M., Xu, J., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698092 · Cited by 255
Brunetti, L., Gundry, M. C., & Goodell, M. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030320 · Cited by 186
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
Gu, Z., Liu, Y., Cai, F., Patrick, M., Zmajkovic, J., Cao, H., Zhang, Y., Tasdogan, A., Chen, M., Qi, L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0152 · Cited by 173
Self-citation
Metadata
- Authors
- Stieglitz, E., Taylor-Weiner, A. N., Chang, T. Y., Gelston, L. C., Wang, Y.-D., Mazor, T., Esquivel, E., Yu, A., Seepo, S., Olsen, S. R., Rosenberg, M., Archambeault, S. L., Abusin, G., Beckman, K., Brown, P. A., Briones, M., Carcamo, B., Cooper, T., Dahl, G. V., Emanuel, P. D., Fluchel, M. N., Goyal, R. K., Hayashi, R. J., Hitzler, J., Hugge, C., Liu, Y. L., Messinger, Y. H., Mahoney, D. H., Monteleone, P., Nemecek, E. R., Roehrs, P. A., Schore, R. J., Stine, K. C., Takemoto, C. M., Toretsky, J. A., Costello, J. F., Olshen, A. B., Stewart, C., Li, Y., Ma, J., Gerbing, R. B., Alonzo, T. A., Getz, G., Gruber, T. A., Golub, T. R., Stegmaier, K., & Loh, M. L.
- Venue
- Nature Genetics
- Published
- 2015-10-12
- Volume
- 47
- Issue
- 11
- Pages
- 1326-1333
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2162079601
- Cited by
- 301
- References
- 70
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.